Aortic Stenosis and TAVI: New Trials, Devices and Data
Published: 02 October 2023
-
Views:
2420
-
Likes:
7
-
Views:
2420
-
Likes:
7
-
9m 2s
-
2m 19sPart 8 Take Home Message
-
2m 4sPart 1 Welcome and Introduction Roxana Mehran, Antoinette Neylon
-
6mPart 2 Treating Aortic Stenosis Earlier – What You Need to Know Martin Swaans
-
6m 51sPart 3 Panel Discussion – Treating Aortic Stenosis Earlier – What You Need to Know Roxana Mehran, Antoinette Neylon, Martin Swaans, Raphael Rosenhek, Haim Danenberg
-
7m 47sPart 4 Overcoming Echo Acquisition Challenges in Aortic Stenosis Raphael Rosenhek
Overview
In this video series, first presented at the ESC Congress 2023 held in Amsterdam, Prof Roxana Mehran, Dr Antoinette Neylon, Dr Martin Swaans, Prof Raphael Rosenhek and Prof Haim Danenberg discuss the Expand II TAVR pivotal trial design and the rational for investigating the treatment of moderate aortic stenosis patients with Evolut™ TAVI, provide practical Echo imaging recommendations to improve aortic stenosis diagnosis in challenging cases, as well as presenting the latest TAVI clinical data on durability, including an outlook of new evidence to expect next and the innovative Evolut™ FX TAVI system.
Click here to watch the NOTION: Nordic Aortic Valve Intervention ESC 2023 Wrap-up.
Learning Objectives
- Learn more about the benefits of detecting aortic stenosis earlier and discover the rationale for the Expand II TAVR pivotal trial
- Appreciate a case-based discussion to enhance your Echo diagnosis of aortic stenosis in challenging patients and anatomies
- Discover new TAVI trials, devices and data on durability and indications
Target Audience
- General Cardiologists
- Interventional Cardiologists
More from this programme
Part 1
Welcome and Introduction
Welcome and introduction of the presenters and learning objectives by Prof Mehran and Dr Neylon.
| 1 session | |
| Welcome and Introduction | Watch now |
Part 2
Treating Aortic Stenosis Earlier – What You Need to Know
Dr Swaans presents the rational for considering the treatment of moderate aortic stenosis patients and the Expand II TAVR pivotal trial design.
Part 3
Panel Discussion – Treating Aortic Stenosis Earlier – What You Need to Know
Panel discussion about moderate aortic stenosis and the challenges to identify the symptomatic patients, as well as questions about the Expand II TAVR pivotal trial design.
Part 4
Overcoming Echo Acquisition Challenges in Aortic Stenosis
Prof Rosenhek presents practical echo imaging tips on how to enhance the echo diagnosis of aortic stenosis in challenging patients.
Part 5
Panel Discussion – Overcoming Echo Acquisition Challenges in Aortic Stenosis
Panel discussion addressing questions on how to avoid the underdiagnosis of patients, especially in women and the importance of calcium scoring as well as the pencil probe to see the jet easier. Furthermore the panel discuss which patients we expect to be seeing in the Expand II TAVR pivotal trial for moderate aortic stenosis patients.
Part 6
TAVI Evolut-ion – Data and New Devices
Prof Danenberg presents hot off the press, new TAVI data including the sub analysis of the 3 year results of the Evolut Low Risk trial of patients below 75 years of age. He explains the differences of existing TAVI valve devices and how their design variances lead to equally different durability outcomes known so far. Furthermore he presents the new Evolut™ FX TAVI system and prospective TAVI data coming up.
Part 7
Panel Discussion – TAVI Evolut-ion – Data and New Devices
Panel discussion about the treatment of younger patients and which valve to consider, Prof Danenbergs’ experience with the new Evolut™ FX TAVI system and the importance of the commissural alignment and other innovations to help improve TAVI patient treatment outcomes.
Part 8
Take Home Message
Dr Neylon summarises the scientific session and shares the take home messages.
| 1 session | |
| Take Home Message | Watch now |
Faculty Biographies
Roxana Mehran
Professor of Medicine, Cardiology and Professor of Population Health Science and Policy
Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a globally respected data and clinical coordination centre to support large, multicentre, multinational clinical trials designed to help improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.
Roxana serves on editorial board of multiple peer reviewed journals, including …
Antoinette Neylon
Interventional Cardiologist
Dr Antoinette Neylon is an Interventional Cardiologist at Cardiovascular Institute Paris Sud, Massy, FR.
She acquired her title of Bachelor of Medicine and Bachelor of Surgery in National University of Ireland.
Raphael Rosenhek
Director Clinic for Valvular Heart Disease
Prof Raphael Rosenhek is the Director Clinic for Valvular Heart Disease at Medical University of Vienna, Vienna, AT.
Prof Rosenhek's research interests include structural heart disease, valvular heart disease and echocardiography with a particular focus on defining the optimal timing and choice of intervention for these conditions.
Haim Danenberg
Head, Interventional Cardiology at Hebrew University of Jerusalem - Hadassah
Haim Danenberg is a professor of medicine and the head of interventional cardiology at the Wolfson Medical Center in Holon, Israel. Prof. Danenberg is the chairman of the Israeli workgroup for Interventional cardiology.
Martin Swaans
Dr Martin Swaans is cardiologist at St Antonius Hospital Nieuwegein in the Netherlands. Dr Swaans specialises in cardiac imaging, particularly in electrophysiology and interventional procedures. He is a frequent speaker at conferences around the globe and a world authority for interventional imaging. Dr Swaans is heavily involved in the development of cutting edge imaging technologies.
Comments